公司資料
Lisata Therapeutics 股價、新聞與催化劑
- 股票代碼:
- LSTA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.08 USD (-0.92%)
收盤價
最後更新: 2026年8月17日
31.7M USD
市值
股價為何變動
As of Aug 17, 2026, LSTA closed down 0.92% at $1.08. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Lisata Therapeutics is a precision oncology company focused on therapies designed to improve tumor penetration and enhance drug delivery into solid tumors. Its story is built around the idea that better access to tumors can improve the performance of other anti-cancer approaches.
所在地與產業分類
Lisata is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotechnology profile. It sits in the development-stage cancer and drug-delivery segment.
商業模式特徵
The company depends on clinical data, partnership potential, and the ability to prove that its platform can improve outcomes in solid tumors. Investors generally watch trial updates, strategic collaborations, and capital needs.
生技產業定位
Lisata occupies a specialized precision-oncology niche within biotech. The stock is driven by the market's view of whether its delivery-focused strategy can create meaningful clinical differentiation.
未來催化劑
- Lisata’s catalysts are certepetide and the pancreatic-cancer / solid-tumor development path, where the next update matters a lot. The company still needs stronger clinical proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。